P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
